Scholar Rock Holding Corp

General ticker "SRRK" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $4.0B

Scholar Rock Holding Corp follows the US Stock Market performance with the rate: 26.5%.

Estimated limits based on current volatility of 4.5%: low 41.64$, high 44.60$

Factors to consider:

  • Current price 82.1% above estimated high
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [9.54$, 24.14$]
  • 2024-12-30 to 2025-12-30 estimated range: [7.80$, 20.24$]

Financial Metrics affecting the SRRK estimates:

  • Negative: Non-GAAP EPS, $ of -1.99 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -9.52 <= 2.35
  • Positive: Inventory ratio change, % of -7.61 <= -1.03
  • Negative: Industry operating profit margin (median), % of -98.30 <= 2.14

Similar symbols

Short-term SRRK quotes

Long-term SRRK plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $18.82MM $33.19MM $0.00MM
Operating Expenses $148.74MM $167.56MM $171.29MM
Operating Income $-129.92MM $-134.37MM $-171.29MM
Non-Operating Income $-1.88MM $-0.13MM $5.51MM
R&D Expense $108.47MM $124.44MM $121.90MM
Income(Loss) $-131.80MM $-134.50MM $-165.79MM
Profit(Loss) $-131.80MM $-134.50MM $-165.79MM
Stockholders Equity $172.07MM $260.24MM $225.22MM
Inventory $0.00MM $2.73MM $0.00MM
Assets $304.44MM $358.17MM $311.04MM
Operating Cash Flow $-126.79MM $-132.69MM $-145.23MM
Capital expenditure $5.25MM $1.06MM $0.07MM
Investing Cash Flow $134.31MM $-171.70MM $41.14MM
Financing Cash Flow $44.95MM $194.83MM $102.57MM
Earnings Per Share* $-3.59 $-2.21 $-1.99

* EPS are Split Adjusted, recent splits may be reflected with a delay.